Bradford Royal Infirmary is a large teaching hospital in Bradford, West Yorkshire, England, and is operated by the Bradford Teaching Hospitals NHS Foundation Trust. The infirmary is affiliated with the Leeds School of Medicine.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Bradford Royal Infirmary
During the past decade, Bradford Royal Infirmary conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 12 clinical trials were completed, i.e. on
average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3%
of trials that started reached the finish line.
Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
2010-03-01
2012-06-01
Completed
525
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Bradford Royal Infirmary" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Boehringer Ingelheim" with 3 trials
sponsored, "University College, London" with 3 trials sponsored, "University of Edinburgh" with 3 trials sponsored and "Belfast Health and Social Care Trust"
with 3 trials sponsored. Other sponsors include 58 different institutions and
companies that sponsored additional 60 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Bradford Royal Infirmary"
#1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "NHS Lothian" with 3 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator. Other collaborators include 54 different institutions and companies that were
collaborators in the rest 61 trials.
Clinical Trials Conditions at Bradford Royal Infirmary
According to Clinical.Site data, the most researched conditions in "Bradford Royal Infirmary" are
"Diabetic Macular Edema" (6 trials), "Asthma" (4 trials), "Geographic Atrophy" (3 trials), "Multiple Myeloma" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Bradford Royal Infirmary" in a lesser frequency.
Clinical Trials Intervention Types at Bradford Royal Infirmary
Most popular intervention types in "Bradford Royal Infirmary" are "Drug" (54 trials), "Procedure" (17 trials), "Other" (11 trials), "Biological" (10 trials) and "Device" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Sham Procedure" (5 trials), "adjuvant therapy" (4 trials), "capecitabine" (4 trials) and "Faricimab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Bradford Royal Infirmary
The vast majority of trials in "Bradford Royal Infirmary" are
73 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Bradford Royal Infirmary
Currently, there are NaN active trials in "Bradford Royal Infirmary".
undefined are not yet recruiting,
11 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 36 completed trials in Bradford Royal Infirmary,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Bradford Royal Infirmary, 3 "Phase 1"
clinical trials were conducted, 25 "Phase 2" clinical
trials and 34 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 13 trials that are defined as “Not Applicable".